Hyperhomocysteinemia and immune activation

Area of Science:

• Biochemistry
• Immunology
• Vascular Biology

Background:

• Hyperhomocysteinemia is a known risk factor for atherosclerosis and thrombosis.
• The precise role of vitamin deficiency and homocysteine accumulation in disease pathogenesis remains unclear.
• Hyperhomocysteinemia often co-occurs with immune system activation in various diseases.

Purpose of the Study:

• To investigate the relationship between immune system activation and homocysteine metabolism.
• To explore whether immune activation contributes to the development of hyperhomocysteinemia.
• To understand the interplay between cellular immunity, vitamin levels, and homocysteine in disease.

Main Methods:

• In vitro experiments with stimulated peripheral blood mononuclear cells.
• Analysis of homocysteine, folate, vitamin B12, neopterin, and peroxide concentrations in patient cohorts (coronary heart disease, rheumatoid arthritis, dementia).
• Correlation studies between immune activation markers and homocysteine/vitamin levels.

Main Results:

• Homocysteine accumulates in stimulated immune cells.
• Inverse correlation between homocysteine and folate levels.
• Positive correlation between homocysteine and immune activation markers (e.g., neopterin).
• In dementia patients, elevated serum peroxides, homocysteine, and neopterin correlate.
• Evidence suggests immune activation contributes to hyperhomocysteinemia development.

Conclusions:

• Immune system activation plays a significant role in the development of hyperhomocysteinemia.
• Immune cell stimulation can lead to oxidative stress, depleting antioxidants and B-vitamins.
• This process can result in increased homocysteine and vitamin deficiency, irrespective of dietary intake.